Glenmark Pharma gets USFDA nod for generic drug

Glenmark Pharma gets USFDA nod for generic drug

The approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, Glenmark said in a statement.

PTIUpdated: Monday, December 19, 2022, 01:19 PM IST
article-image
Glenmark Pharma gets USFDA nod for generic drug | Photo credit: Twitter

Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic nicardipine hydrochloride capsules used to treat high blood pressure and to control angina.

The approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, Glenmark said in an exchange filing.

These are the generic version of Cardene capsules 20 mg and 30 mg of Chiesi USA, Inc, it added.

These will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, the company said.

For the 12-month period ended October 2022, the Cardene capsules 20 mg and 30 mg achieved annual sales of approximately USD 10.9 million, the company said citing IQVIATM sales data.

RECENT STORIES

Nvidia Becomes World's Most Valuable Company, Crosses $4 Trillion Market Value

Nvidia Becomes World's Most Valuable Company, Crosses $4 Trillion Market Value

Asian Paints Sells Entire 4.42% Stake For ₹734 Crore In Akzo Nobel India

Asian Paints Sells Entire 4.42% Stake For ₹734 Crore In Akzo Nobel India

Gold Tumbles ₹700 To ₹98,420/10g, Strong US Dollar & Fed Rate Worries Weigh

Gold Tumbles ₹700 To ₹98,420/10g, Strong US Dollar & Fed Rate Worries Weigh

Adani Enterprises ₹1,000 Crore Bond Issue Fully Subscribed, Investors Respond In Just Three Hours

Adani Enterprises ₹1,000 Crore Bond Issue Fully Subscribed, Investors Respond In Just Three Hours

Centre Tells Delhi High Court There's No Proposal To Issue ₹50 Coin Amid Plea Over Note's...

Centre Tells Delhi High Court There's No Proposal To Issue ₹50 Coin Amid Plea Over Note's...